Please try another search
Hvsen Biotechnology Co., Ltd. engages in the research and development, and manufacture of macrolides APIs and preparations in China and internationally. Its products include tylvalosin tartrate powders and raw materials; florfenicol, cefquinome sulfate, and tildipirosin injections; and florfenicol powder/WSP, tylosin tartrate soluble powder, and tywasin premix products. The company produces various veterinary drug products of raw materials and preparations, as well as traditional Chinese medicines extractives. Hvsen Biotechnology Co., Ltd. was founded in 2002 and is based in Wuhan, China.
Name | Age | Since | Title |
---|---|---|---|
Huobao Xie | 57 | - | Independent Director |
Weiyuan Zhang | 55 | - | Chairman & GM |
Jie Liu | 60 | 2022 | Vice Chairman & Chief Scientist |
Zhenling Zeng | 61 | - | Independent Director |
Zexiang Liu | 48 | 2022 | Director & Assistant to the GM |
Hongxia Li | 48 | - | Director of Warehousing & Logistics Data and Supervisor |
Wenge Ding | 55 | 2022 | Product & Technical Service Director and Supervisor |
Jian Zhou | 50 | 2022 | Chairman of the Supervisory Board & Assistant to the GM |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review